Welch Allyn to distribute RETeval™ DR
LKC Technologies proudly announces an international distribution relationship with Welch Allyn for RETeval DR, LKC's diabetic retinopathy assessment device. RETeval DR is intended for use wherever diabetics meet their care, whether in primary care, endocrinology, or diabetic clinics. LKC has had a long and successful presence in the ophthalmology/optometry market. Welch Allyn has a 99 year history of serving the primary care market. Welch Allyn will distribute the RETeval DR screening version under their name outside of the United States. Welch Allyn will also sell their branded version of the LKC Sensor Strip skin electrodes. LKC will no longer sell the DR version under the LKC brand outside of the US. With this distribution relationship, the RETeval DR products now have the expertise and focus of Welch Allyn in the diabetic market.
LKC is very excited about this new relationship as it will put the RETeval DR device and its capabilities into the hands of those that provide front line care to diabetics worldwide. For more information please contact Kristin Turner at +1 301-840-1992 x125 or email to email@example.com.
In addition to RETeval DR, LKC will continue to sell the RETeval Complete version under the LKC name with LKC Sensor Strips. The RETeval Complete is the world's first non-mydriatic, handheld, ISCEV-compliant, flash-based ERG/VEP device. We believe that RETeval Complete is going to serve the needs of ophthalmologists, optometrists, and hospitals. We believe that RETeval complete will be useful in the diagnosis of glaucoma, ROP, RP, CRVO, uveitis, and other ocular diseases that are currently detected with larger ERG/VEP equipment.